Filing Details

Accession Number:
0001493152-23-000221
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-04 08:30:17
Reporting Period:
2023-01-03
Accepted Time:
2023-01-04 08:30:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1835022 Coya Therapeutics Inc. COYA () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1120478 Md A Dov Goldstein 5850 San Felipe St., Suite 500
Houston, TX 77057
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Per Share Acquisiton 2023-01-03 10,000 $0.00 10,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0001 Per Share Warrant to Purchase Common Stock Acquisiton 2023-01-03 5,000 $0.00 5,000 $7.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,000 2023-01-03 2025-01-03 No 4 P Direct
Footnotes
  1. Reporting Person purchased 10,000 shares of Common Stock and an accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering at a combined purchase price of $5.00 per share and accompanying warrant.